Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Cancer × 90 days × Clear all

NCT04699838 2026-01-02

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Recruiting

Extensive Stage Small Cell Lung Cancer